Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

DocGo Affirms FY2025 Sales Guidance of $300.000M-$330.000M vs $314.472M Est

Author: Benzinga Newsdesk | August 07, 2025 03:24pm
DocGo (NASDAQ:DCGO) affirms FY2025 sales outlook from $300.000 million-$330.000 million to $300.000 million-$330.000 million vs $314.472 million estimate.

Posted In: DCGO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist